MrRowan Milner
DIR & PROF
VM-SACS
GRANTS
- GRANTRNA Loaded Nanoparticle Aggregates for GlioblastomaNational Institute of Health Nci30 Jun 2026 - 30 Jun 2031
- GRANTSpatial Transcriptomic Mapping of Healthy and Neoplastic Gastrointestinal Niches to Advance Diagnosis and Care of Feline GI LymphomaMorris Animal Foundation2 Jun 2026 - 1 Sep 2028
- GRANTOvercoming metastatic spread of osteosarcoma with RNA loaded nanoparticlesNational Institute of Health Nci4 Sep 2025 - 31 Aug 2027
- GRANTThe Florida Summer Training in Research and Oncology for the Next Generation of Researchers (STRONGER) ProgramNational Institute of Health Nci24 Jun 2025 - 31 May 2030
- GRANTAdvancing Canine Health: Liquid Biopsy for Early Relapse Detection and Improved Treatment of Mast Cell TumorsAmerican Kennel Club Canine Health Foundation18 Jan 2025 - 31 Jul 2027
- GRANTMechanisms of immunotolerance in canine oral melanoma: an opportunity to comparative approachesAmerican Kennel Club Canine Health Foundation30 Apr 2024 - 31 Oct 2025
- GRANTImaging, Dosimetry and Radiobiology for a-particle Emitter Radiopharmaceutical TherapyNational Institute of Health Nci12 Feb 2024 - 31 Aug 2028
- GRANTInvestigating the Immune Response to RNA-lipid Nanoparticle Vaccines in a Clinical Trial for Canines with OsteosarcomaPediatric Cancer Research Foundation15 Mar 2023 - 31 Dec 2024
- GRANTOvercoming metastatic spread of osteosarcoma with RNA loaded nanoparticlesNational Institute of Health Nci26 Aug 2022 - 31 Aug 2025
- GRANTMechanism of LSD1 Function and Its Therapeutic Application for Progressive Oral MalignancyNational Institute of Health Nidcr22 Apr 2022 - 31 Jan 2026
- GRANTA GD3 nano-scaled liposomal cancer vaccine for canine hemangiosarcomaAmerican Kennel Club Canine Health Foundation13 Jan 2022 - 28 Feb 2027
- GRANTOvercoming the blood-brain barrier with nanoparticle vaccines against gliomasNational Institute of Health Nci25 Jan 2021 - 31 Jan 2026
- GRANTTranslating Personalized RNA Nanoparticle Vaccines for Oral CancerOcala Royal Dames for Cancer Research1 Jul 2020 - 30 Jun 2024
- GRANTLipidnanoparticle vaccines targeting metastatic lung cancer from osteosarcomaFlorida Department of Health Bankhead-Coley Cancer Re11 Jun 2020 - 31 May 2023
- GRANTCharacterization of Expression and Prognostic Implications of GD2S and GD3S in Canine Histiocytic Sarcoma2 Apr 2020 - 31 Dec 2021
- GRANTNanoparticles targeting genetic translocations in pediatric brain tumorsHyundai Hope On Wheels26 Jun 2019 - 30 Jun 2022
- GRANTHost Immunomodulatory RNA-nanoparticles targeting malignant canine gliomaUF Foundation1 Jul 2018 - 30 Jun 2020
- GRANTAn Immunological Strategy to Osteosarcoma: Reconditioning the Immune System with Adoptive CAR-T Cells and Reversal of Regulatory Pathways.Hyundai Hope On Wheels21 Apr 2017 - 31 Aug 2021
- GRANTCART Cells for SarcomaSARComa Foundation of America6 Apr 2017 - 30 Apr 2019
- GRANTEnvironmental and Genetic Determinants of Transitional Cell Carcinoma of the Urinary Tract in Scottish Terriers funded by Olive's Way27 Aug 2016 - 23 Feb 2020
- GRANTA GD2/GD3 (ganglioside) targeted cancer vaccine for canine osteosarcomaAmerican Kennel Club Canine Health Foundation17 Dec 2015 - 30 Apr 2018
- GRANTA GD2/GD3 (Ganglioside) targeted cancer vaccineUF Foundation20 Aug 2015 - 14 May 2016
- GRANTProspective, multicentre, randomised, double-blind, placebo controlled, 2-parallel groups, phase 3 study to compare efficacy and safety of masitinib to placebo in the treatment of grade 2-3 non-resectable mast cell tumors in dogsAb Science12 May 2015 - 15 May 2019